ICCC Shares Outstanding History



Below is a table of the ICCC shares outstanding history going back to 3/26/2010:

Date ICCC Shares Outstanding
3/26/20102.97M
5/6/20102.97M
8/13/20102.97M
11/5/20102.97M
3/25/20112.97M
5/13/20112.97M
8/12/20112.98M
11/11/20113.00M
3/26/20123.02M
5/11/20123.02M
8/13/20123.02M
11/13/20123.02M
3/20/20133.02M
5/8/20133.02M
8/8/20133.02M
11/8/20133.02M
3/19/20143.03M
5/8/20143.03M
8/8/20143.03M
11/7/20143.03M
3/18/20153.03M
5/7/20153.03M
8/10/20153.06M
11/9/20153.06M
3/17/20164.18M
5/9/20164.18M
8/9/20164.18M
11/8/20164.85M
3/20/20174.85M
5/5/20174.85M
8/9/20175.05M
11/6/20175.05M
3/20/20185.48M
5/8/20185.48M
8/8/20185.48M
11/5/20185.48M
3/18/20195.57M
5/2/20197.21M
8/1/20197.21M
5/7/20182.12M
11/5/20197.21M
3/19/20207.21M
5/5/20207.21M
8/4/20207.21M
10/30/20207.21M
4/30/20217.74M
7/30/20217.74M
10/28/20217.74M
3/18/20227.74M
5/6/20227.74M
11/3/20227.75M
3/10/20237.75M
5/3/20237.75M
8/4/20237.75M
11/1/20237.75M
3/8/20247.75M

Also see: ICCC Market Cap History
ICCC YTD Return
ICCC Historical Shares Outstanding:
+7.11% CAGR
ICCC Historical Shares Outstanding: +7.11% CAGR

Mouse over chart for data details
3/26/2010 ...3/8/2024
ImmuCell is an animal health company. Co. focuses on creating products that improve the health and productivity of dairy and beef cattle. The First Defense® product line provides bovine antibodies that newborn calves need but are unable to produce on their own immediately after birth. The target disease, calf scours (bovine enteritis), causes diarrhea and dehydration in newborn calves and often leads to serious sickness and even death. The First Defense® product line is an orally delivered scours preventive product on the market for calves with claims against E. coli, coronavirus and rotavirus. Co.'s Beyond Vaccination® marketing campaign focuses on providing antibodies without vaccination. We show 56 historical shares outstanding datapoints in our coverage of ICCC's shares outstanding history.

Understanding the changing numbers of ICCC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ICCC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ICCC by allowing them to research ICCC shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ICCC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ImmuCell (ICCC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ICLR Shares Outstanding History
ICPT Shares Outstanding History
ICUI Shares Outstanding History
ICVX Shares Outstanding History
IDRA Shares Outstanding History
IDXG Shares Outstanding History
IDXX Shares Outstanding History
IDYA Shares Outstanding History
IGAP Shares Outstanding History
IGMS Shares Outstanding History
More Healthcare companies »

 

ICCC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.